TrialPloS one2023

A prospective, randomized, non-blinded, non-inferiority pilot study to assess the effect of low-dose anti-thymocyte globulin with low-dose tacrolimus and early steroid withdrawal on clinical outcomes in non-sensitized living-donor kidney recipients.

Youngmin Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.